| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.69 | 0.009 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.009 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.009 |